Developments Exscientia launches AWS AI-powered platform to advance drug discovery Exscientia plc (NASDAQ:EXAI) announced its use of Amazon Web Services (AWS) artificial intelligence and machine learning services to power its platform for end-to-end drug discovery and automation. Exscientia’s... July 10, 2024